ADRENALINUM

ADRENALINUM was reported 42365 times

ADRENALINUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ACCESS SITE COMPLICATION 99 0.3929
1 ALLERGY TO IMMUNOGLOBULIN THERAPY 33 0.3028
2 ACQUIRED FACTOR V DEFICIENCY 27 0.2455
3 COAGULATION FACTOR DEFICIENCY 39 0.2422
4 COAGULATION FACTOR V LEVEL ABNORMAL 27 0.2195
5 INFUSION SITE DISCHARGE 337 0.1920
6 CARDIAC OUTPUT INCREASED 30 0.1754
7 BLOOD LACTIC ACID DECREASED 30 0.1744
8 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 148 0.1394
9 VITAMIN B1 DECREASED 34 0.1355
10 LAGOPHTHALMOS 55 0.1345
11 INFUSION SITE MASS 146 0.1343
12 INFUSION SITE BRUISING 287 0.1327
13 INFUSION SITE PRURITUS 383 0.1213
14 INFUSION SITE URTICARIA 76 0.1134
15 INFUSION SITE SCAR 48 0.1084
16 INFUSION SITE HAEMORRHAGE 354 0.1075
17 HEREDITARY ANGIOEDEMA 1085 0.1010
18 STEROID DEPENDENCE 79 0.0900
19 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 31 0.0891
20 FACTOR V LEIDEN MUTATION 35 0.0882
21 INFUSION SITE RASH 121 0.0881
22 INFUSION SITE SWELLING 552 0.0876
23 CATARRH 79 0.0874
24 INFUSION SITE DISCOMFORT 89 0.0858
25 TOXIC ANTERIOR SEGMENT SYNDROME 88 0.0807
26 MULTIPLE ALLERGIES 609 0.0776
27 ALLERGY TO PLANTS 34 0.0744
28 MATERNAL EXPOSURE DURING DELIVERY 72 0.0727
29 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 64 0.0690
30 INFUSION SITE EXTRAVASATION 410 0.0658
31 IMMUNISATION REACTION 45 0.0625
32 INCORRECT DRUG ADMINISTRATION RATE 266 0.0624
33 STRESS CARDIOMYOPATHY 363 0.0624
34 INSURANCE ISSUE 936 0.0611
35 INFUSION SITE ERYTHEMA 511 0.0606
36 LIQUID PRODUCT PHYSICAL ISSUE 439 0.0601
37 INFUSION SITE PAIN 772 0.0598
38 STATUS ASTHMATICUS 28 0.0593
39 VASOPLEGIA SYNDROME 97 0.0591
40 ALLERGIC SINUSITIS 50 0.0583
41 KOUNIS SYNDROME 130 0.0572
42 MYOPATHY TOXIC 35 0.0566
43 DEVICE INFUSION ISSUE 138 0.0556
44 INFUSION SITE IRRITATION 69 0.0537
45 INFECTED BITE 43 0.0506
46 INFUSION SITE OEDEMA 42 0.0502
47 SEASONAL ALLERGY 710 0.0501
48 INFUSION SITE DISCOLOURATION 43 0.0489
49 INFUSION SITE WARMTH 59 0.0481
50 BURNS SECOND DEGREE 84 0.0478
51 DRY GANGRENE 28 0.0441
52 POOR VENOUS ACCESS 438 0.0423
53 TRACHEITIS 30 0.0394
54 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 32 0.0393
55 INFUSION SITE REACTION 117 0.0391
56 SINUSITIS BACTERIAL 41 0.0389
57 INFUSION SITE NODULE 37 0.0385
58 MAST CELL ACTIVATION SYNDROME 54 0.0385
59 CROUP INFECTIOUS 30 0.0381
60 VASCULAR ACCESS COMPLICATION 30 0.0370
61 ADMINISTRATION SITE PAIN 41 0.0356
62 CATHETER SITE SWELLING 33 0.0353
63 PULSELESS ELECTRICAL ACTIVITY 145 0.0347
64 NOROVIRUS INFECTION 50 0.0346
65 OBSTRUCTION 138 0.0345
66 PHARYNGEAL SWELLING 334 0.0341
67 DISTRIBUTIVE SHOCK 77 0.0340
68 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 74 0.0337
69 POST-ACUTE COVID-19 SYNDROME 41 0.0331
70 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 42 0.0311
71 VEIN RUPTURE 52 0.0310
72 EAR INFECTION 803 0.0301
73 DERMATITIS CONTACT 341 0.0299
74 ARTERIOSPASM CORONARY 119 0.0296
75 ARTHROPOD STING 49 0.0294
76 BODY TEMPERATURE ABNORMAL 54 0.0293
77 RESPIRATORY TRACT INFECTION 763 0.0293
78 IMMUNOGLOBULINS DECREASED 40 0.0291
79 HYPOPNOEA 101 0.0291
80 INFUSION SITE INDURATION 43 0.0290
81 SINUSITIS 2919 0.0285
82 PRODUCT DISTRIBUTION ISSUE 258 0.0278
83 BRASH SYNDROME 39 0.0278
84 ANAESTHETIC COMPLICATION 73 0.0272
85 CHRONIC SINUSITIS 99 0.0264
86 CATHETER SITE PAIN 68 0.0262
87 EXTREMITY NECROSIS 45 0.0258
88 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 84 0.0253
89 ANIMAL BITE 67 0.0251
90 HYPERLACTACIDAEMIA 67 0.0250
91 CARDIOGENIC SHOCK 352 0.0245
92 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 63 0.0240
93 RESPIRATORY TRACT INFECTION VIRAL 55 0.0236
94 CENTRAL VENOUS CATHETERISATION 71 0.0235
95 UPPER RESPIRATORY TRACT INFECTION 1085 0.0235
96 PHARYNGITIS STREPTOCOCCAL 247 0.0228
97 DEVICE FAILURE 332 0.0218
98 GASTROENTERITIS VIRAL 393 0.0217
99 SKIN ABRASION 101 0.0213
100 STREPTOCOCCAL INFECTION 118 0.0212
101 PERIPHERAL ISCHAEMIA 86 0.0210
102 WEIGHT FLUCTUATION 220 0.0210
103 APGAR SCORE LOW 27 0.0209
104 OPHTHALMOPLEGIA 33 0.0209
105 RUBBER SENSITIVITY 32 0.0209
106 BLOOD PH DECREASED 35 0.0205
107 OXYGEN SATURATION ABNORMAL 56 0.0197
108 HAEMODYNAMIC INSTABILITY 150 0.0197
109 RHINITIS 158 0.0196
110 TOOTH INFECTION 257 0.0195
111 RESPIRATORY ACIDOSIS 76 0.0193
112 FOOD ALLERGY 148 0.0192
113 PARANASAL SINUS DISCOMFORT 72 0.0190
114 RHINOVIRUS INFECTION 74 0.0190
115 BRONCHIECTASIS 128 0.0190
116 VENTRICULAR HYPOKINESIA 61 0.0190
117 SKIN INFECTION 213 0.0190
118 LYME DISEASE 63 0.0189
119 INJECTION SITE HYPOAESTHESIA 27 0.0189
120 VASCULAR DEVICE INFECTION 85 0.0187
121 GASTROINTESTINAL INFECTION 167 0.0186
122 IMPAIRED QUALITY OF LIFE 266 0.0185
123 MIDDLE EAR EFFUSION 40 0.0181
124 COMPARTMENT SYNDROME 47 0.0180
125 STRIDOR 53 0.0180
126 TROPONIN I INCREASED 30 0.0180
127 APLASTIC ANAEMIA 92 0.0176
128 SKIN LACERATION 189 0.0174
129 PUPIL FIXED 30 0.0173
130 VIRAL INFECTION 572 0.0172
131 RESPIRATORY SYNCYTIAL VIRUS INFECTION 149 0.0171
132 SINUS DISORDER 338 0.0171
133 HYPERCAPNIA 51 0.0169
134 VENTRICULAR FIBRILLATION 188 0.0169
135 VENTRICULAR ARRHYTHMIA 60 0.0164
136 EYE INFECTION 185 0.0164
137 SUSPECTED COVID-19 54 0.0164
138 INFUSION RELATED REACTION 1081 0.0163
139 MENINGITIS ASEPTIC 73 0.0162
140 VENTRICULAR TACHYCARDIA 268 0.0162
141 BLOOD IMMUNOGLOBULIN G DECREASED 40 0.0161
142 BLOOD LACTIC ACID INCREASED 85 0.0161
143 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 82 0.0160
144 FOOD POISONING 85 0.0159
145 MULTI-ORGAN FAILURE 274 0.0158
146 HORDEOLUM 68 0.0157
147 EYE CONTUSION 33 0.0156
148 PULSE ABSENT 74 0.0155
149 BRONCHITIS 1141 0.0154
150 ARTHROPOD BITE 114 0.0154
151 ALCOHOL POISONING 41 0.0153
152 HAEMATOLOGICAL INFECTION 37 0.0151
153 ANAPHYLACTIC REACTION 833 0.0151
154 ELECTROCARDIOGRAM T WAVE INVERSION 32 0.0145
155 KIDNEY INFECTION 281 0.0143
156 FEAR 384 0.0143
157 INFUSION SITE INFECTION 33 0.0142
158 ORAL PRURITUS 32 0.0139
159 CARDIAC MURMUR 120 0.0139
160 CORNEAL OEDEMA 31 0.0138
161 COVID-19 2424 0.0138
162 SINUS CONGESTION 180 0.0133
163 ILLNESS 1360 0.0132
164 CATHETER SITE HAEMORRHAGE 33 0.0132
165 POST PROCEDURAL INFECTION 107 0.0131
166 TENDERNESS 137 0.0131
167 GASTRIC INFECTION 50 0.0131
168 ATYPICAL PNEUMONIA 39 0.0130
169 PRODUCT COLOUR ISSUE 66 0.0128
170 PARANASAL SINUS HYPERSECRETION 49 0.0128
171 TACHYARRHYTHMIA 32 0.0128
172 ORAL INFECTION 50 0.0128
173 PSEUDOMONAS INFECTION 109 0.0127
174 SINUS TACHYCARDIA 178 0.0125
175 COVID-19 PNEUMONIA 148 0.0125
176 ISCHAEMIA 56 0.0122
177 MYASTHENIA GRAVIS 98 0.0121
178 INFECTIOUS MONONUCLEOSIS 27 0.0120
179 FEAR OF DEATH 27 0.0120
180 PRODUCT PACKAGING CONFUSION 29 0.0119
181 LOCALISED INFECTION 286 0.0118
182 PAROSMIA 89 0.0118
183 RENAL INJURY 350 0.0118
184 RESPIRATORY TRACT CONGESTION 187 0.0118
185 PNEUMONIA VIRAL 37 0.0116
186 VEIN DISORDER 58 0.0116
187 HYPERVOLAEMIA 57 0.0115
188 ELECTROCARDIOGRAM ABNORMAL 90 0.0115
189 INGROWING NAIL 27 0.0114
190 AREFLEXIA 30 0.0112
191 LIGAMENT SPRAIN 111 0.0112
192 SHOCK 256 0.0111
193 PHARYNGITIS 138 0.0111
194 CANDIDA INFECTION 187 0.0111
195 SENSITIVE SKIN 81 0.0110
196 ANHEDONIA 288 0.0109
197 GINGIVAL PAIN 87 0.0109
198 UPPER-AIRWAY COUGH SYNDROME 90 0.0109
199 POST PROCEDURAL COMPLICATION 209 0.0109
200 BRONCHOSPASM 155 0.0109
201 CARDIAC ARREST 892 0.0108
202 TOOTH ABSCESS 109 0.0107
203 ENDOPHTHALMITIS 64 0.0107
204 BRADYCARDIA 559 0.0105
205 METABOLIC ACIDOSIS 334 0.0104
206 ENDOTRACHEAL INTUBATION 29 0.0103
207 ACIDOSIS 79 0.0103
208 CYSTITIS 325 0.0102
209 CARDIOTOXICITY 91 0.0102
210 HEPARIN-INDUCED THROMBOCYTOPENIA 50 0.0101
211 PNEUMONIA BACTERIAL 92 0.0100
212 HAND FRACTURE 71 0.0100
213 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1785 0.0099
214 LIMB INJURY 268 0.0099
215 NEEDLE ISSUE 287 0.0098
216 PRODUCTIVE COUGH 467 0.0098
217 INFLUENZA 1085 0.0097
218 FUNGAL INFECTION 324 0.0097
219 CONCUSSION 75 0.0097
220 COMA SCALE ABNORMAL 28 0.0097
221 BACTERIAL INFECTION 180 0.0096
222 NORMAL NEWBORN 52 0.0096
223 BREATH SOUNDS ABNORMAL 47 0.0095
224 INJECTION SITE DISCHARGE 51 0.0095
225 PRODUCT DOSE OMISSION ISSUE 2780 0.0094
226 URINARY TRACT INFECTION 1591 0.0093
227 SUSPECTED OFF LABEL USE 42 0.0093
228 BLOOD PRESSURE ABNORMAL 183 0.0092
229 MYOCARDIAL ISCHAEMIA 104 0.0091
230 NASOPHARYNGITIS 1682 0.0091
231 BRAIN FOG 143 0.0091
232 LEFT VENTRICULAR DYSFUNCTION 61 0.0091
233 ASTHMA 1028 0.0091
234 AUTOIMMUNE THYROIDITIS 34 0.0090
235 CIRCULATORY COLLAPSE 153 0.0090
236 SUPRAVENTRICULAR TACHYCARDIA 86 0.0090
237 INTENTIONAL PRODUCT USE ISSUE 780 0.0089
238 PNEUMONIA FUNGAL 35 0.0089
239 ANAPHYLACTIC SHOCK 227 0.0088
240 SINUS BRADYCARDIA 84 0.0087
241 INABILITY TO AFFORD MEDICATION 86 0.0087
242 LARYNGEAL OEDEMA 53 0.0086
243 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 146 0.0086
244 ACUTE RESPIRATORY DISTRESS SYNDROME 151 0.0085
245 RHINITIS ALLERGIC 38 0.0085
246 SKIN NECROSIS 44 0.0085
247 HYPOXIA 298 0.0085
248 POSTOPERATIVE WOUND INFECTION 57 0.0084
249 TROPONIN INCREASED 64 0.0084
250 ANGIOEDEMA 372 0.0084
251 ARTHRITIS INFECTIVE 39 0.0084
252 INTESTINAL ISCHAEMIA 46 0.0083
253 MUSCLE STRAIN 72 0.0083
254 PULMONARY HAEMORRHAGE 65 0.0083
255 LACTIC ACIDOSIS 266 0.0082
256 MIGRAINE 779 0.0082
257 RALES 47 0.0081
258 ESCHERICHIA INFECTION 66 0.0080
259 ACUTE PULMONARY OEDEMA 45 0.0080
260 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 137 0.0080
261 SINUS HEADACHE 47 0.0079
262 PRODUCT ADMINISTRATION INTERRUPTED 62 0.0079
263 LIVE BIRTH 66 0.0079
264 STAPHYLOCOCCAL INFECTION 260 0.0079
265 BRAIN INJURY 79 0.0079
266 INJURY 552 0.0078
267 RESPIRATORY DISTRESS 216 0.0078
268 GINGIVITIS 42 0.0078
269 INFECTION 1114 0.0077
270 FUNGAL SKIN INFECTION 31 0.0077
271 OBSTRUCTIVE AIRWAYS DISORDER 85 0.0076
272 VULVOVAGINAL MYCOTIC INFECTION 30 0.0076
273 VENTRICULAR EXTRASYSTOLES 79 0.0076
274 WOUND INFECTION 83 0.0076
275 SCAR 129 0.0075
276 HEART RATE ABNORMAL 42 0.0075
277 OROPHARYNGEAL DISCOMFORT 68 0.0075
278 JOINT INJURY 160 0.0075
279 SWOLLEN TONGUE 233 0.0075
280 MATERNAL EXPOSURE TIMING UNSPECIFIED 28 0.0074
281 EAR DISORDER 34 0.0074
282 LOW BIRTH WEIGHT BABY 59 0.0074
283 FOOD INTOLERANCE 27 0.0074
284 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 50 0.0073
285 FOOT FRACTURE 139 0.0073
286 BUNDLE BRANCH BLOCK LEFT 31 0.0073
287 RESPIRATORY DEPRESSION 89 0.0073
288 UNEVALUABLE EVENT 548 0.0072
289 PRODUCT DOSE OMISSION IN ERROR 205 0.0072
290 CATHETERISATION CARDIAC 32 0.0072
291 ANURIA 62 0.0072
292 ORGAN FAILURE 29 0.0072
293 RESPIRATORY DISORDER 215 0.0072
294 PROCEDURAL HAEMORRHAGE 28 0.0072
295 MOUTH SWELLING 41 0.0071
296 EAR PAIN 138 0.0071
297 PLEURISY 42 0.0071
298 MULTIPLE ORGAN DYSFUNCTION SYNDROME 200 0.0071
299 NASAL CONGESTION 412 0.0070
300 HYPOTENSION 1404 0.0070
301 HYPERAESTHESIA 57 0.0069
302 ATELECTASIS 67 0.0069
303 MATERNAL EXPOSURE DURING BREAST FEEDING 28 0.0069
304 MENINGITIS 46 0.0069
305 ASPERGILLUS INFECTION 45 0.0068
306 TACHYCARDIA 609 0.0068
307 SPUTUM DISCOLOURED 65 0.0068
308 CONJUNCTIVITIS 127 0.0068
309 DYSPHEMIA 30 0.0068
310 WHEEZING 404 0.0068
311 GANGRENE 41 0.0068
312 DIVERTICULITIS 188 0.0068
313 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 354 0.0068
314 AUTOIMMUNE DISORDER 66 0.0068
315 ORAL CANDIDIASIS 89 0.0068
316 WRIST FRACTURE 81 0.0068
317 CELLULITIS 340 0.0067
318 CYANOSIS 105 0.0067
319 TORSADE DE POINTES 52 0.0066
320 DEVICE RELATED INFECTION 102 0.0066
321 PNEUMOTHORAX 105 0.0066
322 LIGAMENT RUPTURE 29 0.0066
323 RESPIRATION ABNORMAL 45 0.0065
324 PARAESTHESIA ORAL 94 0.0065
325 WRONG PRODUCT ADMINISTERED 44 0.0065
326 HYPOVOLAEMIA 38 0.0065
327 NEPHROGENIC ANAEMIA 30 0.0065
328 PNEUMONIA 2076 0.0064
329 UNRESPONSIVE TO STIMULI 165 0.0064
330 ATRIAL FLUTTER 51 0.0064
331 NEPHROLITHIASIS 291 0.0063
332 BUNDLE BRANCH BLOCK RIGHT 29 0.0063
333 EYELID PTOSIS 64 0.0063
334 APNOEA 49 0.0063
335 BODY HEIGHT DECREASED 67 0.0063
336 PULMONARY THROMBOSIS 68 0.0062
337 GENERALISED TONIC-CLONIC SEIZURE 103 0.0062
338 MUSCULOSKELETAL DISCOMFORT 107 0.0062
339 THERMAL BURN 44 0.0062
340 VAGINAL INFECTION 29 0.0062
341 MYDRIASIS 79 0.0062
342 OXYGEN SATURATION DECREASED 344 0.0061
343 VIRAL UPPER RESPIRATORY TRACT INFECTION 29 0.0061
344 PARALYSIS 87 0.0061
345 URINE OUTPUT DECREASED 53 0.0061
346 SARS-COV-2 TEST POSITIVE 80 0.0061
347 PULMONARY OEDEMA 271 0.0060
348 CLOSTRIDIUM DIFFICILE INFECTION 131 0.0060
349 FACIAL PARALYSIS 51 0.0060
350 BODY TEMPERATURE INCREASED 122 0.0060
351 EYE INFLAMMATION 57 0.0060
352 CONTUSION 571 0.0059
353 PREMATURE DELIVERY 94 0.0059
354 BRAIN OEDEMA 74 0.0059
355 BACK DISORDER 95 0.0058
356 ATRIOVENTRICULAR BLOCK COMPLETE 39 0.0058
357 URTICARIA 976 0.0058
358 HEAD INJURY 184 0.0058
359 OROPHARYNGEAL PAIN 537 0.0058
360 PRODUCT AVAILABILITY ISSUE 132 0.0058
361 RIB FRACTURE 119 0.0058
362 COMPLICATION ASSOCIATED WITH DEVICE 84 0.0058
363 COAGULOPATHY 96 0.0058
364 FLANK PAIN 54 0.0058
365 CHEST DISCOMFORT 589 0.0057
366 RESPIRATORY RATE INCREASED 51 0.0057
367 ACCIDENTAL OVERDOSE 210 0.0057
368 IMPAIRED GASTRIC EMPTYING 78 0.0057
369 ACUTE RESPIRATORY FAILURE 110 0.0057
370 RIGHT VENTRICULAR FAILURE 40 0.0057
371 PRODUCT LEAKAGE 32 0.0057
372 SENSITIVITY TO WEATHER CHANGE 30 0.0057
373 NASAL POLYPS 28 0.0057
374 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 312 0.0057
375 TACHYPNOEA 77 0.0057
376 EJECTION FRACTION DECREASED 88 0.0057
377 OLIGURIA 35 0.0056
378 COUGH 1578 0.0056
379 DEVICE OCCLUSION 79 0.0056
380 EPSTEIN-BARR VIRUS INFECTION 35 0.0056
381 HERNIA 108 0.0056
382 ATRIOVENTRICULAR BLOCK 43 0.0056
383 ACUTE CORONARY SYNDROME 46 0.0055
384 CHILLS 650 0.0055
385 BLOOD PRESSURE DECREASED 368 0.0055
386 PRODUCT QUALITY ISSUE 752 0.0055
387 NERVE COMPRESSION 51 0.0055
388 RESPIRATORY FAILURE 400 0.0055
389 PHLEBITIS 28 0.0055
390 PULMONARY CONGESTION 72 0.0055
391 CARDIOMYOPATHY 80 0.0054
392 THERAPY NON-RESPONDER 241 0.0054
393 THROAT TIGHTNESS 145 0.0054
394 SPINAL OPERATION 66 0.0054
395 PARTIAL SEIZURES 28 0.0053
396 PRODUCT PREPARATION ISSUE 35 0.0053
397 HEART RATE INCREASED 527 0.0053
398 BACTERAEMIA 63 0.0053
399 MITRAL VALVE INCOMPETENCE 60 0.0053
400 ANKLE FRACTURE 82 0.0053
401 RENAL FAILURE 701 0.0053
402 WRONG DRUG ADMINISTERED 47 0.0053
403 PELVIC FRACTURE 41 0.0053
404 DISSEMINATED INTRAVASCULAR COAGULATION 74 0.0053
405 RHINORRHOEA 338 0.0052
406 RENAL TUBULAR NECROSIS 51 0.0052
407 ACUTE MYOCARDIAL INFARCTION 152 0.0051
408 DECUBITUS ULCER 42 0.0051
409 HYPOTHERMIA 52 0.0051
410 PRODUCT USE ISSUE 965 0.0051
411 BLOOD PRESSURE INCREASED 781 0.0051
412 CARDIO-RESPIRATORY ARREST 213 0.0051
413 PROCEDURAL COMPLICATION 39 0.0051
414 SWELLING 476 0.0051
415 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 244 0.0051
416 HERPES ZOSTER 290 0.0050
417 SCRATCH 53 0.0050
418 WALKING AID USER 33 0.0050
419 SNEEZING 112 0.0050
420 HEART RATE DECREASED 175 0.0050
421 PROCEDURAL PAIN 137 0.0049
422 CARPAL TUNNEL SYNDROME 69 0.0049
423 HEADACHE 3074 0.0049
424 PULMONARY MASS 73 0.0049
425 POST PROCEDURAL HAEMORRHAGE 57 0.0049
426 SYSTEMIC LUPUS ERYTHEMATOSUS 173 0.0049
427 APHONIA 68 0.0049
428 LIP SWELLING 162 0.0049
429 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 43 0.0049
430 INJECTION SITE EXTRAVASATION 60 0.0049
431 THROAT IRRITATION 218 0.0049
432 HYPERSENSITIVITY 901 0.0048
433 SEPTIC SHOCK 210 0.0048
434 ECZEMA 252 0.0048
435 TOOTH FRACTURE 53 0.0048
436 PYREXIA 1658 0.0048
437 SECRETION DISCHARGE 60 0.0048
438 INTENTIONAL OVERDOSE 307 0.0048
439 STATUS EPILEPTICUS 54 0.0048
440 PERIORBITAL SWELLING 27 0.0048
441 TUBULOINTERSTITIAL NEPHRITIS 89 0.0047
442 ELECTROCARDIOGRAM QT PROLONGED 170 0.0047
443 IMPAIRED WORK ABILITY 101 0.0047
444 PNEUMONIA ASPIRATION 118 0.0047
445 MASS 66 0.0047
446 MENISCUS INJURY 29 0.0047
447 RENAL IMPAIRMENT 396 0.0047
448 PRODUCT USE IN UNAPPROVED INDICATION 1162 0.0047
449 FURUNCLE 37 0.0047
450 WEIGHT DECREASED 1301 0.0047
451 HIATUS HERNIA 60 0.0046
452 PRODUCT SUPPLY ISSUE 33 0.0046
453 ROTATOR CUFF SYNDROME 59 0.0046
454 DYSPNOEA EXERTIONAL 173 0.0046
455 PRODUCT PRESCRIBING ISSUE 100 0.0046
456 OSTEOMYELITIS 83 0.0046
457 SEPSIS 510 0.0046
458 ASPIRATION 50 0.0046
459 ARTHRITIS 358 0.0045
460 BLOOD IRON DECREASED 54 0.0045
461 PHARYNGEAL OEDEMA 70 0.0045
462 CORONAVIRUS INFECTION 30 0.0045
463 VERTIGO 276 0.0045
464 SCOLIOSIS 28 0.0045
465 UPPER LIMB FRACTURE 90 0.0045
466 FALL 1502 0.0045
467 PULMONARY HYPERTENSION 94 0.0045
468 SLEEP APNOEA SYNDROME 86 0.0045
469 NECK PAIN 250 0.0045
470 INTENTIONAL DOSE OMISSION 127 0.0045
471 BLADDER DISORDER 44 0.0044
472 BACK INJURY 48 0.0044
473 VITAMIN D DEFICIENCY 43 0.0044
474 ORAL HERPES 86 0.0044
475 NEURALGIA 107 0.0044
476 PREGNANCY 88 0.0044
477 SKIN SWELLING 38 0.0044
478 LOWER RESPIRATORY TRACT INFECTION 199 0.0044
479 OEDEMA 237 0.0044
480 GASTROINTESTINAL DISORDER 391 0.0044
481 MENTAL STATUS CHANGES 121 0.0044
482 LUNG DISORDER 213 0.0043
483 ROAD TRAFFIC ACCIDENT 181 0.0043
484 SKIN CANCER 93 0.0043
485 COMA 205 0.0043
486 MATERNAL EXPOSURE DURING PREGNANCY 383 0.0043
487 RENAL FAILURE CHRONIC 33 0.0043
488 POLYP 28 0.0043
489 CYST 53 0.0043
490 PALLOR 116 0.0043
491 CATARACT 252 0.0042
492 HYPERTENSIVE CRISIS 47 0.0042
493 ATRIAL FIBRILLATION 410 0.0042
494 ABSCESS 67 0.0042
495 POST-TRAUMATIC STRESS DISORDER 28 0.0042
496 WEIGHT INCREASED 931 0.0042
497 PREMATURE BABY 125 0.0041
498 COLITIS ISCHAEMIC 28 0.0041
499 CARDIOMEGALY 51 0.0041
500 LEUKAEMIA 39 0.0041
501 TINNITUS 189 0.0041
502 EAR DISCOMFORT 42 0.0041
503 ULCER 65 0.0041
504 MUSCLE TIGHTNESS 66 0.0041
505 INFLUENZA LIKE ILLNESS 335 0.0041
506 EMPHYSEMA 41 0.0041
507 PAIN 2488 0.0040
508 ENCEPHALITIS 28 0.0040
509 HYSTERECTOMY 35 0.0040
510 FACIAL PAIN 36 0.0040
511 BLOOD SODIUM DECREASED 76 0.0040
512 TRICUSPID VALVE INCOMPETENCE 32 0.0040
513 THYROID DISORDER 62 0.0040
514 LYMPHADENOPATHY 142 0.0040
515 DYSPNOEA 2269 0.0040
516 MUSCULOSKELETAL CHEST PAIN 62 0.0040
517 PRODUCT USE COMPLAINT 63 0.0040
518 HYPOAESTHESIA ORAL 60 0.0040
519 LIMB DISCOMFORT 123 0.0040
520 ANXIETY 1131 0.0040
521 POOR QUALITY SLEEP 85 0.0039
522 RASH MACULAR 138 0.0039
523 SCAB 45 0.0039
524 EYE PRURITUS 132 0.0039
525 FEAR OF INJECTION 28 0.0039
526 LYMPHOEDEMA 27 0.0039
527 JOINT DISLOCATION 41 0.0039
528 EYELID OEDEMA 45 0.0039
529 DERMATITIS ATOPIC 204 0.0039
530 PALPITATIONS 453 0.0039
531 SEROTONIN SYNDROME 74 0.0038
532 LOWER LIMB FRACTURE 74 0.0038
533 HYPERLIPIDAEMIA 46 0.0038
534 TOXICITY TO VARIOUS AGENTS 645 0.0038
535 BLOOD MAGNESIUM DECREASED 33 0.0038
536 EXPOSURE DURING PREGNANCY 237 0.0038
537 HEART RATE IRREGULAR 86 0.0038
538 ARRHYTHMIA 180 0.0038
539 GENERALISED OEDEMA 47 0.0038
540 INTERVERTEBRAL DISC PROTRUSION 83 0.0038
541 HAEMATOMA 98 0.0038
542 THROMBOSIS 304 0.0038
543 FREQUENT BOWEL MOVEMENTS 102 0.0038
544 HYPERTENSION 798 0.0038
545 THERAPY CHANGE 37 0.0038
546 LEUKOCYTOSIS 68 0.0038
547 SEIZURE 434 0.0038
548 BACK PAIN 866 0.0037
549 CHEST PAIN 683 0.0037
550 ANAL INCONTINENCE 33 0.0037
551 CARDIAC DISORDER 343 0.0037
552 LOSS OF CONSCIOUSNESS 469 0.0037
553 BLOOD POTASSIUM DECREASED 110 0.0037
554 BODY TEMPERATURE DECREASED 36 0.0037
555 BOWEL MOVEMENT IRREGULARITY 28 0.0037
556 SMALL INTESTINAL OBSTRUCTION 45 0.0037
557 RASH PRURITIC 197 0.0036
558 INJECTION SITE SWELLING 278 0.0036
559 DISCOMFORT 221 0.0036
560 DEPRESSED LEVEL OF CONSCIOUSNESS 143 0.0036
561 EOSINOPHIL COUNT INCREASED 30 0.0036
562 NERVE INJURY 40 0.0036
563 FATIGUE 2801 0.0036
564 HYPERSOMNIA 103 0.0036
565 OCULAR DISCOMFORT 40 0.0036
566 PRODUCT ADMINISTRATION ERROR 72 0.0036
567 FEELING COLD 99 0.0036
568 MUSCULAR WEAKNESS 404 0.0036
569 HIP FRACTURE 114 0.0035
570 TOOTH EXTRACTION 44 0.0035
571 ELECTROLYTE IMBALANCE 41 0.0035
572 SWELLING FACE 228 0.0035
573 FULL BLOOD COUNT ABNORMAL 37 0.0035
574 MEDICATION ERROR 194 0.0035
575 DYSPHONIA 204 0.0035
576 RENAL FAILURE ACUTE 148 0.0035
577 SPINAL DISORDER 33 0.0035
578 TOOTHACHE 63 0.0035
579 HAEMOPTYSIS 97 0.0035
580 BLOOD CALCIUM DECREASED 39 0.0035
581 PERICARDIAL EFFUSION 80 0.0035
582 THERAPY INTERRUPTED 247 0.0035
583 PRURITUS 1327 0.0034
584 HEAD DISCOMFORT 61 0.0034
585 SPINAL FRACTURE 69 0.0034
586 DRUG INEFFECTIVE 4536 0.0034
587 SHOCK HAEMORRHAGIC 28 0.0034
588 CONDITION AGGRAVATED 1044 0.0034
589 DECREASED ACTIVITY 37 0.0034
590 LYMPHOMA 53 0.0034
591 DIPLOPIA 89 0.0034
592 FIBROMYALGIA 83 0.0034
593 RECTAL HAEMORRHAGE 146 0.0034
594 LUNG INFILTRATION 30 0.0034
595 HYPERKALAEMIA 119 0.0034
596 INJURY ASSOCIATED WITH DEVICE 69 0.0034
597 SCIATICA 54 0.0034
598 INCORRECT PRODUCT ADMINISTRATION DURATION 73 0.0034
599 EYE DISCHARGE 35 0.0034
600 DEHYDRATION 449 0.0034
601 PERIPHERAL SWELLING 517 0.0034
602 ABDOMINAL DISTENSION 349 0.0033
603 INJECTION SITE DISCOMFORT 35 0.0033
604 APPENDICITIS 31 0.0033
605 HYPOKALAEMIA 153 0.0033
606 EMOTIONAL DISTRESS 400 0.0033
607 COLD SWEAT 58 0.0033
608 PERIPHERAL COLDNESS 45 0.0033
609 HEPATOMEGALY 32 0.0033
610 VITREOUS FLOATERS 32 0.0033
611 UROSEPSIS 30 0.0032
612 IRON DEFICIENCY ANAEMIA 30 0.0032
613 ERYTHEMA 668 0.0032
614 TRANSFUSION 34 0.0032
615 LACRIMATION INCREASED 98 0.0032
616 RASH 1411 0.0032
617 BURSITIS 39 0.0032
618 FEELING HOT 197 0.0032
619 NIGHTMARE 111 0.0032
620 NERVOUS SYSTEM DISORDER 100 0.0032
621 DEEP VEIN THROMBOSIS 208 0.0032
622 WOUND 89 0.0032
623 TUMOUR LYSIS SYNDROME 28 0.0032
624 MALAISE 1390 0.0032
625 FLUID RETENTION 161 0.0032
626 EATING DISORDER 67 0.0031
627 PAIN IN EXTREMITY 924 0.0031
628 INTERVERTEBRAL DISC DEGENERATION 29 0.0031
629 BLOOD URINE PRESENT 59 0.0031
630 PULMONARY EMBOLISM 295 0.0031
631 TOOTH DISORDER 69 0.0031
632 COLITIS ULCERATIVE 137 0.0031
633 GASTROOESOPHAGEAL REFLUX DISEASE 246 0.0031
634 ADRENAL INSUFFICIENCY 37 0.0030
635 PRESCRIBED OVERDOSE 59 0.0030
636 ACCIDENTAL EXPOSURE TO PRODUCT 314 0.0030
637 NEOPLASM 35 0.0030
638 SLUGGISHNESS 31 0.0030
639 ECONOMIC PROBLEM 46 0.0030
640 LETHARGY 174 0.0030
641 PLEURAL EFFUSION 184 0.0030
642 ACCIDENT 36 0.0030
643 EXPIRED PRODUCT ADMINISTERED 100 0.0030
644 SLEEP DISORDER 212 0.0030
645 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 213 0.0030
646 SKIN HAEMORRHAGE 44 0.0030
647 RASH ERYTHEMATOUS 141 0.0029
648 PRODUCT PACKAGING ISSUE 28 0.0029
649 INCREASED TENDENCY TO BRUISE 27 0.0029
650 ACUTE KIDNEY INJURY 447 0.0029
651 FLUSHING 296 0.0029
652 SYNCOPE 291 0.0029
653 EYE SWELLING 108 0.0029
654 OBESITY 46 0.0029
655 IMMUNE SYSTEM DISORDER 38 0.0029
656 RHABDOMYOLYSIS 120 0.0029
657 SKIN DISCOLOURATION 132 0.0029
658 EPISTAXIS 214 0.0029
659 PAIN IN JAW 81 0.0029
660 VOMITING 1344 0.0029
661 GALLBLADDER DISORDER 51 0.0029
662 RASH PAPULAR 64 0.0029
663 GASTRITIS 75 0.0028
664 COLITIS 108 0.0028
665 KNEE OPERATION 28 0.0028
666 IRRITABLE BOWEL SYNDROME 61 0.0028
667 SKIN REACTION 40 0.0028
668 BASAL CELL CARCINOMA 44 0.0028
669 CHOKING 55 0.0028
670 NAUSEA 2230 0.0028
671 DYSARTHRIA 106 0.0028
672 ABDOMINAL DISCOMFORT 472 0.0028
673 TEMPERATURE INTOLERANCE 29 0.0028
674 DYSPHAGIA 266 0.0028
675 DENTAL CARIES 31 0.0028
676 DYSURIA 103 0.0028
677 GOUT 50 0.0028
678 TRANSIENT ISCHAEMIC ATTACK 94 0.0028
679 DIZZINESS POSTURAL 27 0.0028
680 ENCEPHALOPATHY 68 0.0028
681 BURNING SENSATION 194 0.0028
682 DRY EYE 138 0.0028
683 HAEMATOCHEZIA 152 0.0028
684 PANIC ATTACK 100 0.0027
685 NEUROTOXICITY 48 0.0027
686 ILEUS 34 0.0027
687 INTESTINAL OBSTRUCTION 103 0.0027
688 RENAL DISORDER 127 0.0027
689 PHOTOSENSITIVITY REACTION 45 0.0027
690 INJECTION SITE PRURITUS 182 0.0027
691 FEEDING DISORDER 55 0.0027
692 DERMATITIS ALLERGIC 34 0.0027
693 DRUG EFFECT LESS THAN EXPECTED 40 0.0027
694 HYPOPHAGIA 69 0.0027
695 WHITE BLOOD CELL COUNT INCREASED 103 0.0027
696 INJECTION SITE ERYTHEMA 332 0.0027
697 PRESYNCOPE 65 0.0027
698 BLOOD PRESSURE SYSTOLIC INCREASED 52 0.0027
699 INCONTINENCE 28 0.0026
700 BLOOD POTASSIUM INCREASED 43 0.0026
701 DEVICE MALFUNCTION 186 0.0026
702 INJECTION SITE DISCOLOURATION 33 0.0026
703 CLOSTRIDIUM DIFFICILE COLITIS 28 0.0026
704 HEPATIC STEATOSIS 49 0.0026
705 OSTEOPOROSIS 108 0.0026
706 DERMATITIS 55 0.0026
707 SOMNOLENCE 527 0.0026
708 EYE DISORDER 86 0.0026
709 INJECTION SITE URTICARIA 64 0.0026
710 SPEECH DISORDER 136 0.0026
711 ARTHRALGIA 1076 0.0026
712 PETECHIAE 27 0.0026
713 TREMOR 428 0.0026
714 SKIN DISORDER 86 0.0026
715 RESPIRATORY ARREST 71 0.0026
716 BLOOD UREA INCREASED 43 0.0026
717 FACE OEDEMA 43 0.0025
718 FEELING ABNORMAL 607 0.0025
719 MACULAR DEGENERATION 30 0.0025
720 HAEMORRHOIDS 49 0.0025
721 HAEMORRHAGE 261 0.0025
722 OCULAR HYPERAEMIA 118 0.0025
723 CARDIAC FAILURE CONGESTIVE 199 0.0025
724 CEREBROVASCULAR ACCIDENT 417 0.0025
725 INJECTION SITE MASS 91 0.0025
726 HYPERHIDROSIS 317 0.0025
727 NO THERAPEUTIC RESPONSE 30 0.0025
728 BLOOD PRESSURE FLUCTUATION 59 0.0025
729 DIZZINESS 1223 0.0024
730 NODULE 32 0.0024
731 SKIN LESION 67 0.0024
732 INJECTION SITE IRRITATION 31 0.0024
733 DEVICE ISSUE 218 0.0024
734 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 82 0.0024
735 KNEE ARTHROPLASTY 51 0.0024
736 HEPATIC FAILURE 73 0.0024
737 MALNUTRITION 27 0.0024
738 HYPOKINESIA 35 0.0024
739 NEUROPATHY PERIPHERAL 229 0.0024
740 SYRINGE ISSUE 42 0.0024
741 GLAUCOMA 46 0.0024
742 HYPOAESTHESIA 356 0.0024
743 HAEMATOCRIT DECREASED 47 0.0024
744 OFF LABEL USE 2065 0.0024
745 SURGERY 138 0.0024
746 THERAPEUTIC RESPONSE SHORTENED 78 0.0023
747 BLISTER 132 0.0023
748 INJECTION SITE RASH 72 0.0023
749 AGITATION 172 0.0023
750 GASTROENTERITIS 34 0.0023
751 DRUG INTERACTION 366 0.0023
752 PLATELET COUNT INCREASED 30 0.0023
753 MENTAL DISORDER 100 0.0023
754 MYOCLONUS 27 0.0023
755 UPPER GASTROINTESTINAL HAEMORRHAGE 38 0.0023
756 RESTLESS LEGS SYNDROME 41 0.0023
757 APHASIA 68 0.0022
758 EYE HAEMORRHAGE 30 0.0022
759 INJECTION SITE BRUISING 179 0.0022
760 MUSCLE SPASMS 411 0.0022
761 NERVOUSNESS 117 0.0022
762 QUALITY OF LIFE DECREASED 30 0.0022
763 DISABILITY 44 0.0022
764 DEPRESSION 503 0.0022
765 GASTRIC ULCER 42 0.0022
766 INFLAMMATION 114 0.0022
767 FEELING JITTERY 42 0.0022
768 ABDOMINAL PAIN 512 0.0022
769 PANCREATITIS 116 0.0022
770 OEDEMA PERIPHERAL 267 0.0022
771 GAIT INABILITY 73 0.0022
772 EYE IRRITATION 125 0.0022
773 INJECTION SITE REACTION 149 0.0022
774 ADVERSE DRUG REACTION 194 0.0022
775 HIP ARTHROPLASTY 33 0.0022
776 ORAL PAIN 48 0.0021
777 MIDDLE INSOMNIA 40 0.0021
778 HYPERGLYCAEMIA 78 0.0021
779 TENDONITIS 33 0.0021
780 ASTHENIA 801 0.0021
781 FLUID OVERLOAD 31 0.0021
782 HOSPITALISATION 327 0.0021
783 CHROMATURIA 48 0.0021
784 HEMIPARESIS 36 0.0021
785 DEVICE USE ISSUE 37 0.0021
786 ADVERSE REACTION 28 0.0021
787 INCORRECT DOSE ADMINISTERED 481 0.0021
788 FOETAL EXPOSURE DURING PREGNANCY 170 0.0021
789 INJECTION SITE INDURATION 27 0.0021
790 PARAESTHESIA 327 0.0021
791 OVERDOSE 447 0.0021
792 INCORRECT ROUTE OF DRUG ADMINISTRATION 74 0.0021
793 CEREBRAL HAEMORRHAGE 74 0.0021
794 DIARRHOEA 1333 0.0021
795 DELIRIUM 71 0.0020
796 PRODUCT PREPARATION ERROR 42 0.0020
797 CARDIAC FAILURE 163 0.0020
798 ABDOMINAL PAIN UPPER 418 0.0020
799 END STAGE RENAL DISEASE 37 0.0020
800 MEMORY IMPAIRMENT 278 0.0020
801 NEOPLASM MALIGNANT 135 0.0020
802 PHOTOPHOBIA 38 0.0020
803 DEVICE DEFECTIVE 35 0.0020
804 MALIGNANT MELANOMA 27 0.0020
805 THERAPEUTIC RESPONSE DECREASED 122 0.0020
806 CONFUSIONAL STATE 325 0.0020
807 INJECTION SITE PAIN 615 0.0020
808 BLOOD GLUCOSE ABNORMAL 37 0.0020
809 EYE PAIN 113 0.0020
810 RED BLOOD CELL COUNT DECREASED 57 0.0020
811 JOINT SWELLING 239 0.0020
812 IMPAIRED HEALING 65 0.0020
813 TREATMENT NONCOMPLIANCE 108 0.0020
814 RETCHING 42 0.0020
815 DEPRESSED MOOD 104 0.0020
816 BALANCE DISORDER 170 0.0020
817 HAEMOGLOBIN DECREASED 200 0.0019
818 IMMUNODEFICIENCY 29 0.0019
819 SKIN FISSURES 38 0.0019
820 OSTEOPENIA 29 0.0019
821 DIALYSIS 27 0.0019
822 HAEMATEMESIS 48 0.0019
823 HEPATIC ENZYME INCREASED 129 0.0019
824 HYPOGLYCAEMIA 91 0.0019
825 DRUG LEVEL INCREASED 31 0.0019
826 ANOSMIA 27 0.0019
827 BLINDNESS 76 0.0019
828 CHOLELITHIASIS 61 0.0019
829 DIABETES MELLITUS 141 0.0018
830 NO ADVERSE EVENT 335 0.0018
831 POLLAKIURIA 77 0.0018
832 MYALGIA 313 0.0018
833 OSTEOARTHRITIS 78 0.0018
834 FULL BLOOD COUNT DECREASED 37 0.0018
835 SUICIDE ATTEMPT 111 0.0018
836 URINARY RETENTION 61 0.0018
837 VISION BLURRED 250 0.0018
838 CORONARY ARTERY DISEASE 55 0.0018
839 DYSGEUSIA 134 0.0018
840 CYTOKINE RELEASE SYNDROME 36 0.0018
841 THIRST 32 0.0018
842 SKIN IRRITATION 82 0.0018
843 MYOCARDIAL INFARCTION 312 0.0018
844 SKIN ULCER 46 0.0018
845 CHRONIC KIDNEY DISEASE 135 0.0018
846 DECREASED APPETITE 412 0.0018
847 PHARMACEUTICAL PRODUCT COMPLAINT 46 0.0018
848 DRY SKIN 236 0.0018
849 PNEUMONITIS 48 0.0018
850 SKIN EXFOLIATION 148 0.0018
851 DEVICE LEAKAGE 76 0.0018
852 DISORIENTATION 69 0.0017
853 ABDOMINAL PAIN LOWER 44 0.0017
854 NIGHT SWEATS 56 0.0017
855 DRUG EFFECT INCOMPLETE 63 0.0017
856 GAIT DISTURBANCE 330 0.0017
857 MUSCULOSKELETAL STIFFNESS 151 0.0017
858 ANAEMIA 327 0.0017
859 ARTHROPATHY 95 0.0017
860 FAECES DISCOLOURED 37 0.0017
861 FEBRILE NEUTROPENIA 113 0.0017
862 ASCITES 50 0.0017
863 BLOOD TRIGLYCERIDES INCREASED 30 0.0017
864 INJECTION SITE WARMTH 34 0.0017
865 THROMBOCYTOPENIA 184 0.0016
866 ALTERED STATE OF CONSCIOUSNESS 35 0.0016
867 MENTAL IMPAIRMENT 39 0.0016
868 BLOOD CREATININE INCREASED 105 0.0016
869 MUCOSAL INFLAMMATION 42 0.0016
870 SEDATION 42 0.0016
871 STOMATITIS 97 0.0016
872 CONSTIPATION 348 0.0016
873 ILL-DEFINED DISORDER 96 0.0016
874 DRUG ERUPTION 28 0.0016
875 UNDERDOSE 115 0.0016
876 DISTURBANCE IN ATTENTION 84 0.0016
877 BONE PAIN 91 0.0016
878 TREATMENT FAILURE 128 0.0015
879 BLOOD CREATINE PHOSPHOKINASE INCREASED 44 0.0015
880 TASTE DISORDER 31 0.0015
881 LABORATORY TEST ABNORMAL 45 0.0015
882 DYSPEPSIA 150 0.0015
883 URINARY INCONTINENCE 45 0.0015
884 BLOOD BILIRUBIN INCREASED 41 0.0015
885 ISCHAEMIC STROKE 27 0.0015
886 PULMONARY FIBROSIS 29 0.0015
887 GASTROINTESTINAL HAEMORRHAGE 126 0.0015
888 RESTLESSNESS 55 0.0015
889 LIVER DISORDER 66 0.0015
890 CRYING 54 0.0015
891 BLOOD GLUCOSE DECREASED 71 0.0015
892 DEVICE BREAKAGE 60 0.0015
893 GENERAL PHYSICAL HEALTH DETERIORATION 171 0.0015
894 THERAPEUTIC PRODUCT EFFECT DECREASED 66 0.0015
895 CEREBRAL INFARCTION 36 0.0015
896 HYPOTHYROIDISM 47 0.0015
897 DRUG ADMINISTRATION ERROR 45 0.0015
898 INCREASED APPETITE 28 0.0015
899 INSOMNIA 390 0.0015
900 VISUAL IMPAIRMENT 181 0.0015
901 DRUG INTOLERANCE 140 0.0014
902 JOINT STIFFNESS 38 0.0014
903 PLATELET COUNT DECREASED 154 0.0014
904 RASH MACULO-PAPULAR 32 0.0014
905 HEPATIC CIRRHOSIS 27 0.0014
906 IRRITABILITY 86 0.0014
907 EXPOSURE VIA SKIN CONTACT 37 0.0014
908 INJECTION SITE HAEMORRHAGE 114 0.0014
909 EMOTIONAL DISORDER 44 0.0014
910 HYPOCALCAEMIA 27 0.0014
911 TYPE 2 DIABETES MELLITUS 48 0.0014
912 DEVICE DELIVERY SYSTEM ISSUE 39 0.0014
913 HOT FLUSH 106 0.0014
914 HYPOACUSIS 60 0.0014
915 MUSCULOSKELETAL PAIN 73 0.0014
916 MOBILITY DECREASED 100 0.0014
917 CARDIOVASCULAR DISORDER 35 0.0014
918 DEMENTIA 38 0.0014
919 MUSCLE TWITCHING 31 0.0013
920 ANGINA PECTORIS 38 0.0013
921 FEMUR FRACTURE 41 0.0013
922 LIVER FUNCTION TEST INCREASED 28 0.0013
923 DYSSTASIA 38 0.0013
924 DEAFNESS 34 0.0013
925 ASPARTATE AMINOTRANSFERASE INCREASED 69 0.0013
926 INTERNATIONAL NORMALISED RATIO INCREASED 37 0.0013
927 HAEMATURIA 44 0.0013
928 MOUTH ULCERATION 27 0.0013
929 VISUAL ACUITY REDUCED 42 0.0013
930 LIVER FUNCTION TEST ABNORMAL 36 0.0012
931 PRODUCT STORAGE ERROR 108 0.0012
932 HYPONATRAEMIA 69 0.0012
933 HEPATOTOXICITY 27 0.0012
934 AGEUSIA 30 0.0012
935 DEATH 1021 0.0012
936 DYSKINESIA 48 0.0012
937 ABORTION SPONTANEOUS 47 0.0012
938 DRY MOUTH 95 0.0012
939 INTENTIONAL PRODUCT MISUSE 102 0.0012
940 RHEUMATOID ARTHRITIS 132 0.0012
941 WHITE BLOOD CELL COUNT DECREASED 126 0.0012
942 EXTRA DOSE ADMINISTERED 47 0.0012
943 BLOOD CHOLESTEROL INCREASED 54 0.0012
944 FLATULENCE 64 0.0011
945 DIABETIC KETOACIDOSIS 27 0.0011
946 PAIN OF SKIN 30 0.0011
947 COGNITIVE DISORDER 52 0.0011
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 223 0.0011
949 MOVEMENT DISORDER 35 0.0011
950 ALANINE AMINOTRANSFERASE INCREASED 66 0.0011
951 AMNESIA 69 0.0011
952 GASTRIC DISORDER 36 0.0010
953 THERAPEUTIC RESPONSE UNEXPECTED 47 0.0010
954 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 48 0.0010
955 PSORIATIC ARTHROPATHY 41 0.0010
956 SKIN BURNING SENSATION 72 0.0010
957 PANCYTOPENIA 56 0.0010
958 CONVULSION 56 0.0010
959 DRUG DOSE OMISSION BY DEVICE 76 0.0010
960 NEUTROPHIL COUNT DECREASED 39 0.0010
961 ALOPECIA 181 0.0009
962 DEVICE DISLOCATION 40 0.0009
963 DISEASE PROGRESSION 107 0.0009
964 BLOOD GLUCOSE INCREASED 170 0.0009
965 PRODUCT DOSE OMISSION 58 0.0009
966 EPILEPSY 27 0.0009
967 NEUTROPENIA 119 0.0009
968 BREAST CANCER 80 0.0009
969 WRONG TECHNIQUE IN DRUG USAGE PROCESS 31 0.0009
970 OSTEONECROSIS 28 0.0009
971 C-REACTIVE PROTEIN INCREASED 31 0.0009
972 HEPATIC FUNCTION ABNORMAL 31 0.0008
973 INTERSTITIAL LUNG DISEASE 39 0.0008
974 PLASMA CELL MYELOMA 31 0.0008
975 ABNORMAL BEHAVIOUR 31 0.0008
976 ADVERSE EVENT 72 0.0008
977 SUICIDAL IDEATION 70 0.0008
978 LEUKOPENIA 38 0.0008
979 PSORIASIS 99 0.0008
980 LUNG NEOPLASM MALIGNANT 31 0.0008
981 THERAPY CESSATION 38 0.0007
982 AGGRESSION 37 0.0007
983 MULTIPLE SCLEROSIS 35 0.0007
984 VAGINAL HAEMORRHAGE 30 0.0007
985 ACNE 51 0.0007
986 HALLUCINATION 50 0.0007
987 DISEASE RECURRENCE 27 0.0006
988 COMPLETED SUICIDE 46 0.0006
989 DRUG ABUSE 37 0.0004
990 MALIGNANT NEOPLASM PROGRESSION 44 0.0004
991 DEVICE DIFFICULT TO USE 28 0.0004
992 MULTIPLE SCLEROSIS RELAPSE 28 0.0004
993 DRUG DOSE OMISSION 40 0.0002